News | May 21, 2008

Researchers Recognized for MRI for Atrial Fibrillation Technique

May 22, 2008 - Nassir Marrouche, M.D., and his research team from the University of Utah School of Medicine received the Eric N. Prystowsky Fellow Clinical Research award for their abstract on experimental studies showing how magnetic resonance imaging (MRI) angiograms can be effectively used during atrial fibrillation (AF) procedures.

The award was presented at Heart Rhythm 2008, held in San Francisco, May 14-17. The winning entry from Dr. Marrouche, Dr. Marcos Daccarett and their colleagues was an abstract entitled, “Quantitative Measurement and Three Dimensional Visualization of Scar Formation Following Pulmonary Vein Isolation for Atrial Fibrillation.”

“We appreciate this honor and are proud to be the first program in the country to focus on refining image-based heart ablation procedures using MRI,” said Dr. Marrouche, the director of the Atrial Fibrillation Program at the University of Utah School of Medicine.

Treatment of AF often involves radiofrequency (RF) ablation, a procedure in which the electrical signals that cause the heart to contract at a chaotic, usually rapid rate are mapped, localized, and then destroyed (i.e., ablated) using RF energy. Since MRI offers the most detailed information about normal and damaged myocardial tissue, Dr. Marrouche is investigating its use in patient screening, procedure planning, procedure navigation and localizing the causes of post-procedural complications.

The purpose of his research is to improve the curative rates and safety of RF ablation procedures. At the American College of Cardiology conference earlier this year, he presented the first study to show how MRI can be used as a precise, pre-procedure diagnostic tool to visually demonstrate AF’s progression and location. And last October, the University of Utah AF program became the first in the world to be able to ablate using a catheter custom-made to be compatible with MRI.

Dr. Marrouche has performed more than 1,000 ablation procedures, and about 90% of his patients are arrhythmia free and off heart medications within three months of their procedures. Their major complication rates are less than 0.5%, more 12 times better than the comparable 6% rate in a 2005 worldwide survey of the ablation procedure outcomes.

The Heart Rhythm Society's Eric N. Prystowsky Fellow Clinical Research award is given to the top three highest scoring abstracts submitted to the Clinical Electrophysiology, Catheter Ablation or Devices categories.

For more information: www.hrsonline.org

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
360 Photos | Magnetic Resonance Imaging (MRI) | May 17, 2019
This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas.
Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI
News | Magnetic Resonance Imaging (MRI) | May 17, 2019
Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition X 1.5T MR, the world’s...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing